课题基金 / 基金详情

Identifying and exploiting novel pharmacological targets for breast cancer

Identifying and exploiting novel pharmacological targets for breast cancer
识别和开发乳腺癌的新药理学靶点
批准号:
nhmrc : 1141008
负责人:
Dr Felicity Davis
金额:
$29.14万
依托单位国家:
澳大利亚
项目类别:
Career Development Fellowships
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-01-01 至 2021-12-31

项目摘要

项目成果

Dr Felicity Davis的其他基金

相似基金

相关文献

中文摘要
翻译
乳腺癌由不同类型的癌细胞组成,并不是所有的细胞都起同样的作用。癌细胞的一个子集可能具有独特的驱动肿瘤生长的能力,在治疗后重建致命的肿瘤,并在远处建立新的肿瘤。识别和开发调节这些细胞活性和存活的途径将带来更好的治疗模式,并为乳腺癌患者走向无复发的未来。
英文摘要
Breast cancers are made up of different types of cancer cells, and not all cells contribute equally. A subset of cancer cells may be uniquely capable of driving tumor growth, rebuilding fatal tumors after therapy and establishing new tumors at distant sites. Identifying and exploiting the pathways that regulate the activity and survival of these cells will lead to better modes of treatment, and move towards a relapse-free future for breast cancer patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying and exploiting novel pharmacological targets for breast cancer treatment
  • 批准号:
    nhmrc : GNT1138214
  • 项目类别:
    Project Grants
  • 资助金额:
    $44.22万
  • 财政年份:
    2018
  • 负责人:
    Dr Felicity Davis
  • 依托单位:
Identifying and exploiting novel pharmacological targets for breast cancer
  • 批准号:
    nhmrc : GNT1141008
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $43.1万
  • 财政年份:
    2018
  • 负责人:
    Dr Felicity Davis
  • 依托单位:
Identifying and exploiting novel pharmacological targets for breast cancer treatment
  • 批准号:
    nhmrc : 1138214
  • 项目类别:
    Project Grants
  • 资助金额:
    $29.9万
  • 财政年份:
    2018
  • 负责人:
    Dr Felicity Davis
  • 依托单位:
Investigating the cellular requirement for STIM1 phosphorylation and store-operated calcium entry suppression during mitosis: roles in development and cancer
  • 批准号:
    nhmrc : 1071074
  • 项目类别:
    Early Career Fellowships
  • 资助金额:
    $23.0万
  • 财政年份:
    2014
  • 负责人:
    Dr Felicity Davis
  • 依托单位:
海外基金